Spreafico, A., Heirali, A. A., Araujo, D. V., Tan, T. J., Oliva, M., Schneeberger, P. H. H., . . . Coburn, B. (2023). First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO trial).
Citación estilo ChicagoSpreafico, Anna, et al. First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in Combination With Immune Checkpoint Inhibitors in Patients With Advanced Solid Tumors (MET4-IO Trial). 2023.
Cita MLASpreafico, Anna, et al. First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in Combination With Immune Checkpoint Inhibitors in Patients With Advanced Solid Tumors (MET4-IO Trial). 2023.
Precaución: Estas citas no son 100% exactas.